Atlas Trials

ARX788 in Breast Cancer With Low Expression of HER2

Clinical trial NCT05018676 · UNKNOWN

Trial details

NCT number
NCT05018676
Sponsor
Fudan University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer With Low Expression of HER2
Start date
2021-10-20
Primary completion
2022-12-30
Enrollment
54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.